Advertisement

Topics

Latest "Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD)" News Stories

20:25 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD)" found in our extensive news archives from over 250 global news sources.

More Information about Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD) for you to read. Along with our medical data and news we also list Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novelogics Biotechnology, Inc. and The Centre for Drug Research and Development (CDRD) Companies for you to search.

Showing "Novelogics Biotechnology Centre Drug Research Development CDRD" News Articles 1–25 of 49,000+

Tuesday 26th March 2019

Understanding Gene Interactions Holds Key to Personalized Medicine

NewsWhen the Human Genome Project was completed, in 2003, it opened the door to a radical new idea of health—that of personalized medicine.


Novo Nordisk Files for US FDA Approval of Oral Semaglutide for Blood Sugar Control and Cardiovascular Risk Reduction in Adults with Type 2 Diabetes

PLAINSBORO, N.J., March 20, 2019 /PRNewswire/ -- Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral semaglutide, the first once-daily glucagon-like peptide-1 (GLP-1)...

Health2Sync, CTBC Bank and Bitmark Launch World's First Diabetes Data Trust

Groundbreaking blockchain trust enhances diabetes research by securing patient medical records, speeding data access and streamlining payments. TAIPEI, Taiwan, March 26, 2019 /PRNewswire/ -- Health2Sync, a leader in diabetes management, has partnered with CTBC Bank and Bitmark to establish the world's first diabetes data trust; an extremely secure, yet t...


Shineco, Inc. Receives Regional Government Merchants Invitation for its Industrial Hemp Business Line

BEIJING, March 26, 2019 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and other health and well-being focused plant-based products in China, announced today that the Company received a merchant's invitation (the "Invitation"...

Greenberg Traurig’s Evan Holden Speaks at National Academy of Sciences Roundtable on Biomedical Engineering Materials Applications

Evan Holden, a shareholder in the Atlanta office of global law firm Greenberg Traurig, LLP, was a panelist at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA) March 25 in Washington D.C. at NAS’ Keck Center. ATLANTA (PRWEB) March 26, 2019 Evan Holden, a shareholder in the Atlanta office of global law firm Greenberg Traurig, LLP, was a pan...

Remifentanil Hydrochloride Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Remifentanil Hydrochloride report provides an independent information about the Remifentanil Hydrochloride industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent...

Curadite, Inc. Selected for National Epilepsy Foundation Shark Tank Competition

Curadite, Inc. will compete for awards totaling up to $200,000 in the Epilepsy Foundation Shark Tank Finals, which take place in Aventura, FL on May 23, 2019 at the

Apollo Endosurgery Appoints John Barr to Board of Directors

The Board of Directors of Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that John Barr has been appointed to Apollo’s Board of Directors as an independent director, effective immediately. Mr. Barr will join 9 other directors, a majority of wh...

Drug Rationing Common for Shortages, Patient Disclosure Rare

A new survey shows that in this era of continuing drug shortages rationing is common in hospitals and patients aren't always aware. Medscape Medical News

PlayCore releases newest evidence-based publication, the Science of Play, featuring work by Dr. Stuart Brown

Treatise of articles helps expand knowledge of play as an important element of life for people of all ages CHATTANOOGA, Tenn. (PRWEB) March 26, 2019 PlayCore releases newest evidence-based publication, the Science of Play, featuring work by Dr. Stuart Brown Renowned play expert Dr Stuart Brown is committed to bringing the unrealized knowledge, practices, and benefits of play into public life. Thr...

Hartig Drug names new CEO

The RepHresh™ Brand Launches NEW RepHresh Cooling Relief Vaginal Anti-Itch Spray

Relieves External Feminine Itch and Neutralizes Odor. Available for Distribution April 2019. On shelf and available to customers nationwide in July. The RepHresh brand launches NEW RepHresh Cooling Relief Vaginal Anti-Itch Spray to relieve external feminine itch and neutralize odor. The product will be available for retail distribution on April ...

Biotechnology meets fashion and sports performance: Trends in the apparel industry

Spiders, mushrooms and algae may help build the next Hilfiger, Levi and Chanel. Organisms are the great designers of our planet, producing materials in distinct patterns to serve a specific function. Bees produce hexagonal honeycombs to store honey, spiders weave symmetrical webs to capture prey, and nautiluses form a logarithmic spiral shell to protect their […] The post Biotechnology meets...

New research from our collaboration with @karolinskainst, published today, sheds new light on the role of liver macrophages in insulin resistance. The findings could change our understanding of non-inflammatory pathways in #MetabolicDisease. Read more: h

New research from our collaboration with @karolinskainst, published today, sheds new light on the role of liver macrophages in insulin resistance. The findings could change our understanding of non-inflammatory pathways in #MetabolicDisease. Read more: http://bit.ly/2Opu337  pic.twitter.com/rLWPB8enRc

Triplex Meets Primary Endpoint in Phase 2 Clinical Trial, Reduces Rate of Cytomegalovirus (CMV) Complications in Transplant Recipients by 50 Percent

First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem cell transplant recipients City of Hope, a world-renowned cancer research and treatment center, announced today that Triplex has met its primary endpoint (reduction of CMV events) in a

Pulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual Conference

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX™ System, today announced that key findings from its clinical programs using Nano-Pulse Stimulation™ (NPS™) technology will be presented at the American Society for Laser Medicine and Surgery’s (ASLMS) Annual Conference being held March 27-31, ...

Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction

Settlement will establish national center for addiction studies and treatment in Tulsa; Sackler family announces voluntary contribution to support national center Purdue Pharma L.P. today announced that it has entered into a landmark agreement with the state of Oklahoma that will establish a National Center for Addiction Studies and Treatment...

Statement of Dr. Mortimer and Dr. Raymond Sackler Families Regarding Purdue Pharma’s Settlement with State of Oklahoma

The Dr. Mortimer and Dr. Raymond Sackler families today issued the following statement in connection with Purdue Pharma’s settlement with the State of Oklahoma: We are pleased to participate in the unique landmark agreement announced today with Attorney General Hunter and Purdue Pharma that will result in the establishment of a National Center f...

Research Team Invents a New Mode of Photoacoustic Imaging

NewsWhat kind of sounds do biological structures make? Moreover, how can we listen to them?

Biomarkers and drug targets could be discovered using new deep-learning method http://ow.ly/qzQC30oce0s pic.twitter.com/HPHGpXb5hE

Biomarkers and drug targets could be discovered using new deep-learning method http://ow.ly/qzQC30oce0s  pic.twitter.com/HPHGpXb5hE

Publisher’s Spotlight: 2019 CARE Awards Finalists

Informa Pharma Intelligence is delighted to announce the shortlist for the 2019 Clinical and Research Excellence Awards, to be presented...    

New research from our collaboration with @karolinksainst, published today, sheds new light on the role of liver macrophages in insulin resistance. The findings could change our understanding of non-inflammatory pathways in #MetabolicDisease. Read more: h

New research from our collaboration with @karolinksainst, published today, sheds new light on the role of liver macrophages in insulin resistance. The findings could change our understanding of non-inflammatory pathways in #MetabolicDisease. Read more: http://bit.ly/2Opu337  pic.twitter.com/IizHGfkv0O

Roche quietly discontinues Ignyta cancer therapy RXDX-105

Roche’s RXDX-105, which was being developed by Ignyta, has had its development discontinued, according to an industry source. The move...Read More... The post Roche quietly discontinues Ignyta cancer therapy RXDX-105 appeared first on Pharmaceutical Technology.

Press Ganey Releases State-of-the-Art Digital Platform to Advance Health Care Workforce Transformation

Enhanced capabilities deliver industry’s only integrated view across engagement, resilience, and safety culture Press Ganey today announced the release of its advanced Workforce and Engagement Solution, enabling health care systems to measure, identify, and act on improvement opportunities at unprecedented levels. The platform delive...

CURE® Magazine Names 2019 Extraordinary Healer® Award Finalists

The three finalists are oncology nurses who have gone above and beyond for cancer patients. CURE Media Group’s flagship product, CURE® magazine, which services over a million patients, survivors and caregivers dedicated to providing cancer updates, proudly announces Barbara Bittner, RN, OCN; Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON; and Angela Hamm...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks